BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 37567029)

  • 1. Renal Medullary Carcinoma: A Surveillance, Epidemiology, and End Results (SEER) Analysis.
    Haupt T; Akinyemi O; Raju RA; Wadley AE; Nnorom S; Aponte V; Thelus J; Tonkin JB; Coleman PW; Metwalli AR
    J Surg Res; 2023 Dec; 292():1-6. PubMed ID: 37567029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Racial disparities in overall survival among renal cell carcinoma patients with young age and small tumors.
    Schwartz K; Ruterbusch JJ; Colt JS; Miller DC; Chow WH; Purdue MP
    Cancer Med; 2016 Feb; 5(2):200-8. PubMed ID: 26710924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal medullary carcinoma: A national analysis of 159 patients.
    Ezekian B; Englum B; Gilmore BF; Nag UP; Kim J; Leraas HJ; Routh JC; Rice HE; Tracy ET
    Pediatr Blood Cancer; 2017 Nov; 64(11):. PubMed ID: 28485059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management and outcomes of patients with renal medullary carcinoma: a multicentre collaborative study.
    Shah AY; Karam JA; Malouf GG; Rao P; Lim ZD; Jonasch E; Xiao L; Gao J; Vaishampayan UN; Heng DY; Plimack ER; Guancial EA; Fung C; Lowas SR; Tamboli P; Sircar K; Matin SF; Kimryn Rathmell W; Wood CG; Tannir NM
    BJU Int; 2017 Dec; 120(6):782-792. PubMed ID: 27860149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is renal medullary carcinoma the seventh nephropathy in sickle cell disease? A multi-center Nigerian survey.
    Anazoeze M; Najibah G; Garba U; Shehu A; Florence F; Abdulaziz H; Marcus I; Oluwaseun A; Theresa N; Obike I; Sunday O; Ifeoma E; Anthony I; Barth C; Chide O; Joseph O; Malachy I; Kaladada K; Uche A; Kingsley A; Charles N; Angela U; Augustin D; Chikwudi A; Alozie E; Uchenna O; Caroline O; Obineche A; Iheanyi O
    Afr Health Sci; 2016 Jun; 16(2):490-6. PubMed ID: 27605964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Updated Recommendations on the Diagnosis, Management, and Clinical Trial Eligibility Criteria for Patients With Renal Medullary Carcinoma.
    Msaouel P; Hong AL; Mullen EA; Atkins MB; Walker CL; Lee CH; Carden MA; Genovese G; Linehan WM; Rao P; Merino MJ; Grodman H; Dome JS; Fernandez CV; Geller JI; Apolo AB; Daw NC; Hodges HC; Moxey-Mims M; Wei D; Bottaro DP; Staehler M; Karam JA; Rathmell WK; Tannir NM
    Clin Genitourin Cancer; 2019 Feb; 17(1):1-6. PubMed ID: 30287223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal Medullary Carcinoma: a Report of the Current Literature.
    Blas L; Roberti J; Petroni J; Reniero L; Cicora F
    Curr Urol Rep; 2019 Jan; 20(1):4. PubMed ID: 30656488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors associated with survival in paediatric and adolescent renal cell carcinoma: a population-based study.
    Zhao L; Liu W; Chu L; Luo L
    ANZ J Surg; 2023 Nov; 93(11):2710-2715. PubMed ID: 37458221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal medullary carcinoma involving serous cavity fluids: a cytomorphologic study of 12 cases.
    Miller DL; Ribeiro EA; Roy-Chowdhuri S; Illei PB; Siddiqui MT; Ali SZ
    J Am Soc Cytopathol; 2021; 10(2):187-196. PubMed ID: 32651128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal medullary carcinoma in a white adolescent with sickle cell trait.
    Daher P; Bourgi A; Riachy E; Khoury A; Rehayem C; Sader-Ghorra C
    J Pediatr Hematol Oncol; 2014 Jul; 36(5):e285-9. PubMed ID: 24517963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Race and renal cell carcinoma stage at diagnosis: an analysis of the Surveillance, Epidemiology, and End Results data.
    Lin J; Kamamia C; Shriver CD; Zhu K
    Eur J Cancer Prev; 2019 Jul; 28(4):350-354. PubMed ID: 30376467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal Medullary Carcinoma and Sickle Cell Trait: A Push for Early Diagnosis and Intervention Report of Two Cases.
    Carter SA; Walker AN
    J Natl Med Assoc; 2017 Spring; 109(1):63-65. PubMed ID: 28259220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology of malignant cutaneous granular cell tumors: A US population-based cohort analysis using the Surveillance, Epidemiology, and End Results (SEER) database.
    Mirza FN; Tuggle CT; Zogg CK; Mirza HN; Narayan D
    J Am Acad Dermatol; 2018 Mar; 78(3):490-497.e1. PubMed ID: 28989104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal cell carcinoma, unclassified with medullary phenotype: poorly differentiated adenocarcinomas overlapping with renal medullary carcinoma.
    Sirohi D; Smith SC; Ohe C; Colombo P; Divatia M; Dragoescu E; Rao P; Hirsch MS; Chen YB; Mehra R; Amin MB
    Hum Pathol; 2017 Sep; 67():134-145. PubMed ID: 28716439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Racial disparities in renal cell carcinoma: a single-payer healthcare experience.
    Mafolasire A; Yao X; Nawaf C; Suarez-Sarmiento A; Chow WH; Zhao W; Corley D; Hofmann JN; Purdue M; Adeniran AJ; Shuch B
    Cancer Med; 2016 Aug; 5(8):2101-8. PubMed ID: 27228559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal Medullary Carcinoma: Establishing Standards in Practice.
    Beckermann KE; Sharma D; Chaturvedi S; Msaouel P; Abboud MR; Allory Y; Bourdeaut F; Calderaro J; de Cubas AA; Derebail VK; Hong AL; Naik RP; Malouf GG; Mullen EA; Reuter VE; Roberts CWM; Walker CL; Wood CG; DeBaun MR; Van Poppel H; Tannir NM; Rathmell WK
    J Oncol Pract; 2017 Jul; 13(7):414-421. PubMed ID: 28697319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of locally advanced and metastatic disease in patients with small renal masses.
    Kates M; Korets R; Sadeghi N; Pierorazio PM; McKiernan JM
    BJU Int; 2012 May; 109(10):1463-7. PubMed ID: 21933329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic challenges of renal medullary carcinoma and the role for cytologic assessment: Case report and literature review.
    Severseike BO; Schafernak KT; Willard SD; Goncalves LF; Kothari AK; Eshun FK; Mangum R
    J Clin Lab Anal; 2023 Apr; 37(4):e24854. PubMed ID: 36843202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of gender in renal cell carcinoma: an analysis of the SEER database.
    Aron M; Nguyen MM; Stein RJ; Gill IS
    Eur Urol; 2008 Jul; 54(1):133-40. PubMed ID: 18160207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathological characteristics and outcomes of synchronous renal cell carcinoma and urothelial carcinoma: A population-based analysis.
    Wu K; Liu X; Wang Y; Wang X; Li X
    Front Public Health; 2022; 10():994351. PubMed ID: 36388369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.